Expression of Adenovirus Type 5 E1A in the Methylotrophic Yeast Yeast Pachia pastris and the Inhibitory Effect on S-180 Tumor Growth
-
- Ma Yewei
- Cancer Institute, Peking Union Medical College and Chinese Academy of Medical Sciences
-
- Zhou Xiaoshan
- Cancer Institute, Peking Union Medical College and Chinese Academy of Medical Sciences
-
- Zhao Qingzheng
- Cancer Institute, Peking Union Medical College and Chinese Academy of Medical Sciences
-
- Li Yanchun
- Cancer Institute, Peking Union Medical College and Chinese Academy of Medical Sciences
-
- Liu Yuying
- Cancer Institute, Peking Union Medical College and Chinese Academy of Medical Sciences
-
- Wang Zheng
- Cancer Institute, Peking Union Medical College and Chinese Academy of Medical Sciences
-
- Zhang Yangpei
- Cancer Institute, Peking Union Medical College and Chinese Academy of Medical Sciences
書誌事項
- タイトル別名
-
- Expression of Adenovirus Type 5 E1A in the Methylotrophic Yeast Pachia pastoris and the Inhibitory Effect on S-180 Tumor Growth.
この論文をさがす
説明
The human adenovirus type 5 (Ad5) early-region 1A (E1A) proteins have been shown to have strong tumor-suppressive activities in human tumor cells and to enhance the sensitivity of a variety of malignant tumors to apoptosis induced by ionizing radiation and chemotherapeutic agents. However, the inherent limitations of E1A gene therapy prevent its application, such as the efficiency of expression, precision of targeting, and toxicity of vector. This prompted us to construct an E1A expression vector (pPIC9/E1A) and express the E1A protein in the methylotrophic yeast Pichia pastoris. The E1A protein was purified using two steps of ion-exchange column chromatography on HiTrap Q and HiTrap SP. The analysis indicated that the E1A protein/liposome inhibited S-180 tumor growth and also rendered the S-180 tumor strongly susceptible to the anticancer drug bleomycin in vivo. Furthermore, tunnel assay clearly revealed that the mechanism was induction of cellular apoptosis. Importantly, the E1A protein overcame the limitations of gene therapy. Thus the E1A protein may be a useful therapeutic agent for some malignant tumors.
収録刊行物
-
- Biological & Pharmaceutical Bulletin
-
Biological & Pharmaceutical Bulletin 26 (2), 137-140, 2003
公益社団法人 日本薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679601964544
-
- NII論文ID
- 110003608391
-
- NII書誌ID
- AA10885497
-
- COI
- 1:CAS:528:DC%2BD3sXjsFCqtro%3D
-
- ISSN
- 13475215
- 09186158
-
- NDL書誌ID
- 6418845
-
- PubMed
- 12576670
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可